Guillain-Barré syndrome in a 93-year-old woman: rapid improvement of neurologic function following intravenous immunoglobulin.
We treated a 93-year-old woman with Guillain-Barré syndrome (GBS) with high-dose intravenous immunoglobulin (IgIV). The patient improved within 48 hours of the onset of treatment. There were no adverse side effects.
Uldry
P A
PA
Department of Neurology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Bogousslavsky
J
J
Regli
F
F
D000368:Aged; D000369:Aged, 80 and over; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000134:cerebrospinal fluid; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D009460:Neurologic Examination; D011129:Polyradiculoneuropathy / Q000276:immunology / Q000628:therapy*
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous